SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-047261
Filing Date
2024-11-21
Accepted
2024-11-21 21:53:44
Documents
1
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3092
  Complete submission text file 0001493152-24-047261.txt   4476
Mailing Address 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Yu John S (Reporting) CIK: 0001550545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42275 | Film No.: 241486219

Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Issuer) CIK: 0001962011 (see all company filings)

IRS No.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)